VEGFA and lung cancer: This is a class-related effect of VEGF inhibitors, but management with oral antihypertensive drugs is usually direct and effective; increased vascular events, both arterial and venous, have been seen with bevacizumab in patients with colon cancer and need to be considered in patients with lung cancer.